Collegium Pharmaceutical
COLL
COLL
72 hedge funds and large institutions have $307M invested in Collegium Pharmaceutical in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 38 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-11
Holders Change %
-13.25%
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
38
Reduced
16
Closed
16
Calls
$149K
Puts
$529K
Net Calls
-$380K
Net Calls Change
-$639K
Top Buyers
| 1 |
CCM
Cadian Capital Management
New York
|
$28.2M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
$22.6M |
| 3 |
BlackRock
New York
|
$23.2M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
$14M |
| 5 |
Millennium Management
New York
|
$4.37M |
